GB9417366D0 - Cell cycle regulated repressor and DNA element - Google Patents

Cell cycle regulated repressor and DNA element

Info

Publication number
GB9417366D0
GB9417366D0 GB9417366A GB9417366A GB9417366D0 GB 9417366 D0 GB9417366 D0 GB 9417366D0 GB 9417366 A GB9417366 A GB 9417366A GB 9417366 A GB9417366 A GB 9417366A GB 9417366 D0 GB9417366 D0 GB 9417366D0
Authority
GB
United Kingdom
Prior art keywords
cell cycle
dna element
cycle regulated
regulated repressor
repressor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9417366A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Topotarget UK Ltd
Original Assignee
Behringwerke AG
Prolifix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke AG, Prolifix Ltd filed Critical Behringwerke AG
Priority to GB9417366A priority Critical patent/GB9417366D0/en
Publication of GB9417366D0 publication Critical patent/GB9417366D0/en
Priority to GBGB9506466.3A priority patent/GB9506466D0/en
Priority to PCT/GB1995/002000 priority patent/WO1996006943A1/en
Priority to PT95929181T priority patent/PT802985E/en
Priority to IL11505195A priority patent/IL115051A0/en
Priority to ZA9507074A priority patent/ZA957074B/en
Priority to CA002198080A priority patent/CA2198080A1/en
Priority to US08/793,660 priority patent/US6214614B1/en
Priority to DE69529174T priority patent/DE69529174T2/en
Priority to ES95929181T priority patent/ES2190787T3/en
Priority to DK95929181T priority patent/DK0802985T3/en
Priority to AU32639/95A priority patent/AU711012B2/en
Priority to AT95929181T priority patent/ATE229569T1/en
Priority to EP95929181A priority patent/EP0802985B1/en
Priority to NZ29149595A priority patent/NZ291495A/en
Priority to JP8508548A priority patent/JPH10508188A/en
Priority to EP95931205A priority patent/EP0807183B1/en
Priority to DK95930524T priority patent/DK0777739T3/en
Priority to ES95930524T priority patent/ES2146770T3/en
Priority to US08/793,107 priority patent/US5830880A/en
Priority to EP95931933A priority patent/EP0777740B1/en
Priority to CA002198462A priority patent/CA2198462A1/en
Priority to DE59509100T priority patent/DE59509100D1/en
Priority to CN95195134A priority patent/CN1158144A/en
Priority to AU33874/95A priority patent/AU690733B2/en
Priority to PT95931204T priority patent/PT804601E/en
Priority to DK95931933T priority patent/DK0777740T3/en
Priority to JP8508478A priority patent/JPH10505234A/en
Priority to AU34732/95A priority patent/AU696593B2/en
Priority to AT95931205T priority patent/ATE198492T1/en
Priority to JP8508479A priority patent/JPH10506526A/en
Priority to DE59508945T priority patent/DE59508945D1/en
Priority to DE59508145T priority patent/DE59508145D1/en
Priority to EP95931204A priority patent/EP0804601B1/en
Priority to JP50848096A priority patent/JP2002502228A/en
Priority to AU34733/95A priority patent/AU690336B2/en
Priority to PCT/EP1995/003369 priority patent/WO1996006939A1/en
Priority to PCT/EP1995/003370 priority patent/WO1996006940A1/en
Priority to AT95931933T priority patent/ATE191507T1/en
Priority to US08/793,109 priority patent/US6384202B1/en
Priority to CA002198472A priority patent/CA2198472A1/en
Priority to EP95930524A priority patent/EP0777739B1/en
Priority to CA002198474A priority patent/CA2198474A1/en
Priority to AT95930524T priority patent/ATE191506T1/en
Priority to ES95931933T priority patent/ES2146775T3/en
Priority to DK95931205T priority patent/DK0807183T3/en
Priority to ES95931205T priority patent/ES2153045T3/en
Priority to PT95931933T priority patent/PT777740E/en
Priority to AT95931204T priority patent/ATE199741T1/en
Priority to DK95931204T priority patent/DK0804601T3/en
Priority to PT95931205T priority patent/PT807183E/en
Priority to RU97104482/14A priority patent/RU2197992C2/en
Priority to PT95930524T priority patent/PT777739E/en
Priority to ES95931204T priority patent/ES2155137T3/en
Priority to PCT/EP1995/003371 priority patent/WO1996006941A1/en
Priority to PCT/EP1995/003368 priority patent/WO1996006938A1/en
Priority to KR1019970701226A priority patent/KR970705638A/en
Priority to US08/793,110 priority patent/US6358732B1/en
Priority to DE59508144T priority patent/DE59508144D1/en
Priority to JP8508477A priority patent/JPH10507626A/en
Priority to CA002198473A priority patent/CA2198473A1/en
Priority to AU35185/95A priority patent/AU695458B2/en
Priority to FI970674A priority patent/FI113787B/en
Priority to FI970768A priority patent/FI970768A/en
Priority to GR20000401227T priority patent/GR3033535T3/en
Priority to GR20000401226T priority patent/GR3033534T3/en
Priority to GR20010400149T priority patent/GR3035322T3/en
Priority to GR20010400847T priority patent/GR3035994T3/en
Priority to US10/112,953 priority patent/US20030018005A1/en
Pending legal-status Critical Current

Links

GB9417366A 1994-08-26 1994-08-26 Cell cycle regulated repressor and DNA element Pending GB9417366D0 (en)

Priority Applications (69)

Application Number Priority Date Filing Date Title
GB9417366A GB9417366D0 (en) 1994-08-26 1994-08-26 Cell cycle regulated repressor and DNA element
GBGB9506466.3A GB9506466D0 (en) 1994-08-26 1995-03-29 Cell cycle regulated repressor and dna element
PCT/GB1995/002000 WO1996006943A1 (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and dna element
PT95929181T PT802985E (en) 1994-08-26 1995-08-23 REPRESSOR REGULATED BY CELL CYCLE AND DNA ELEMENT
IL11505195A IL115051A0 (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and dna element
ZA9507074A ZA957074B (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and DNA element.
CA002198080A CA2198080A1 (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and dna element
US08/793,660 US6214614B1 (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and DNA element
DE69529174T DE69529174T2 (en) 1994-08-26 1995-08-23 CELL CYCLE REGULATED REPRESSOR AND DNA ELEMENT
ES95929181T ES2190787T3 (en) 1994-08-26 1995-08-23 REPRESSOR REGULATED BY THE CELL CYCLE AND DNA ELEMENT.
DK95929181T DK0802985T3 (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and DNA element
AU32639/95A AU711012B2 (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and DNA element
AT95929181T ATE229569T1 (en) 1994-08-26 1995-08-23 CELL CYCLE REGULATED REPRESSOR AND DNA ELEMENT
EP95929181A EP0802985B1 (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and dna element
NZ29149595A NZ291495A (en) 1994-08-26 1995-08-23 Cell cycle regulated repressor and DNA element
JP8508548A JPH10508188A (en) 1994-08-26 1995-08-23 Cell cycle regulatory repressor and DNA element
EP95931205A EP0807183B1 (en) 1994-08-26 1995-08-25 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
DK95930524T DK0777739T3 (en) 1994-08-26 1995-08-25 Gene therapeutic treatment of vascular disease with a cell-specific cell cycle-dependent active substance
ES95930524T ES2146770T3 (en) 1994-08-26 1995-08-25 TREATMENT OF GENE THERAPY OF VASCULAR DISEASES THROUGH AN ACTIVE CYTO-SPECIFIC SUBSTANCE AND DEPENDENT ON THE CELL CYCLE.
US08/793,107 US5830880A (en) 1994-08-26 1995-08-25 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
EP95931933A EP0777740B1 (en) 1994-08-26 1995-08-25 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
CA002198462A CA2198462A1 (en) 1994-08-26 1995-08-25 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
DE59509100T DE59509100D1 (en) 1994-08-26 1995-08-25 GENTHERAPEUTIC TREATMENT OF TUMORS WITH AN ENDOTHEL CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
CN95195134A CN1158144A (en) 1994-08-26 1995-08-25 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
AU33874/95A AU690733B2 (en) 1994-08-26 1995-08-25 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
PT95931204T PT804601E (en) 1994-08-26 1995-08-25 TREATMENT OF TUMORS FOR GENETIC THERAPY WITH A SPECIFIC ACTIVE INGREDIENT OF ENDOTHELIAL CELLS DEPENDING ON THE CELL CYCLE
DK95931933T DK0777740T3 (en) 1994-08-26 1995-08-25 Gene Therapeutic Treatment of Central Nervous System Disorders (CNS) with a Cell-Specific Cell Cycle-Dependent Active Stomach
JP8508478A JPH10505234A (en) 1994-08-26 1995-08-25 Gene therapy of diseases of the central nervous system using cell-specific active compounds that are cell cycle dependent
AU34732/95A AU696593B2 (en) 1994-08-26 1995-08-25 Gene therapy of tumours with an endothelial cell-specific, cell cycle-dependent active compound
AT95931205T ATE198492T1 (en) 1994-08-26 1995-08-25 GENE THERAPY OF DISEASES CAUSED BY THE IMMUNE SYSTEM USING A CELL-SPECIFIC CELL CYCLE-REGULATED ACTIVE SUBSTANCE
JP8508479A JPH10506526A (en) 1994-08-26 1995-08-25 Gene Therapy for Tumors Using Active Compounds Dependent on Endothelial Cells-Specific Cell Cycle
DE59508945T DE59508945D1 (en) 1994-08-26 1995-08-25 GENE THERAPY OF DISEASES CONDITIONED BY THE IMMUNE SYSTEM WITH THE AID OF A CELL-SPECIFIC CELL-CYCLE-REGULATED ACTIVE SUBSTANCE
DE59508145T DE59508145D1 (en) 1994-08-26 1995-08-25 GENTHERAPEUTIC TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) BY A CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
EP95931204A EP0804601B1 (en) 1994-08-26 1995-08-25 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
JP50848096A JP2002502228A (en) 1994-08-26 1995-08-25 Gene therapy of diseases related to the immune system using active compounds specific to cells controlled by the cell cycle
AU34733/95A AU690336B2 (en) 1994-08-26 1995-08-25 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
PCT/EP1995/003369 WO1996006939A1 (en) 1994-08-26 1995-08-25 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
PCT/EP1995/003370 WO1996006940A1 (en) 1994-08-26 1995-08-25 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
AT95931933T ATE191507T1 (en) 1994-08-26 1995-08-25 GENETHERAPEUTIC TREATMENT OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) USING A CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
US08/793,109 US6384202B1 (en) 1994-08-26 1995-08-25 Cell-specific active compounds regulated by the cell cycle
CA002198472A CA2198472A1 (en) 1994-08-26 1995-08-25 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
EP95930524A EP0777739B1 (en) 1994-08-26 1995-08-25 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
CA002198474A CA2198474A1 (en) 1994-08-26 1995-08-25 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
AT95930524T ATE191506T1 (en) 1994-08-26 1995-08-25 GENETHERAPEUTIC TREATMENT OF VASCULAR DISEASES USING A CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
ES95931933T ES2146775T3 (en) 1994-08-26 1995-08-25 TREATMENT OF GENE THERAPY OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) THROUGH A SPECIFIC ACTIVE INGREDIENT OF THE CELLS AND INDEPENDENT OF THE CELL CYCLE.
DK95931205T DK0807183T3 (en) 1994-08-26 1995-08-25 Gene therapy of diseases caused by the immune system by a cell-specific active substance regulated by cellec
ES95931205T ES2153045T3 (en) 1994-08-26 1995-08-25 GENE THERAPY OF DISEASES CONDITIONED BY THE IMMUNE SYSTEM, WITH HELP OF A SPECIFIC ACTIVE ACTIVE SUBSTANCE OF THE CELL AND REGULATED BY THE CELL CYCLE.
PT95931933T PT777740E (en) 1994-08-26 1995-08-25 TREATMENT FOR GENETIC THERAPY OF DISEASES OF THE CENTRAL NERVOUS SYSTEM (CNS) THROUGH A SPECIFIC ACTIVE SUBSTANCE OF CELL CYCLE DEPENDENT CELLS
AT95931204T ATE199741T1 (en) 1994-08-26 1995-08-25 GENE THERAPEUTICAL TREATMENT OF TUMORS WITH AN ENDOTHELIAL CELL-SPECIFIC, CELL CYCLE-DEPENDENT ACTIVE SUBSTANCE
DK95931204T DK0804601T3 (en) 1994-08-26 1995-08-25 Gene therapeutic treatment of tumors with an endothelial cell-specific active substance that is cell cycle dependent
PT95931205T PT807183E (en) 1994-08-26 1995-08-25 GENETIC THERAPY OF DISEASES INDUCED BY THE IMMUNE SYSTEM WITH THE ASSISTANCE OF A REGULATORY SUBSTANCE OF THE CELL SPECIFIC CELL CYCLE
RU97104482/14A RU2197992C2 (en) 1994-08-26 1995-08-25 Method for applying genetic therapy of vascular diseases by means of active substance specific to cell and dependant on cellular cycle
PT95930524T PT777739E (en) 1994-08-26 1995-08-25 TREATMENT OF DISEASES OF VASES THROUGH GENETIC THERAPY THROUGH A SPECIFIC ACTIVE MATERIAL OF CELLS AND CELL CYCLE DEPENDENT
ES95931204T ES2155137T3 (en) 1994-08-26 1995-08-25 TREATMENT FOR GENETIC TUMOR THERAPY WITH A SPECIFIC ACTIVE ACTIVE SUBSTANCE OF ENDOTELIAL CELLS AND DEPENDENT ON THE CELL CYCLE.
PCT/EP1995/003371 WO1996006941A1 (en) 1994-08-26 1995-08-25 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
PCT/EP1995/003368 WO1996006938A1 (en) 1994-08-26 1995-08-25 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
KR1019970701226A KR970705638A (en) 1994-08-26 1995-08-25 Genetic therapies for tumors using endothelial cell-specific, cell cycle-dependent active compounds (Genetic therapy of tumors with an endothelial cell-specific active substance,
US08/793,110 US6358732B1 (en) 1994-08-26 1995-08-25 DNA for expression under control of a cell cycle-dependent promoter
DE59508144T DE59508144D1 (en) 1994-08-26 1995-08-25 GENTHERAPEUTIC TREATMENT OF VASCULAR DISEASES BY A CELL-SPECIFIC, CELL-CYCLE-DEPENDENT ACTIVE SUBSTANCE
JP8508477A JPH10507626A (en) 1994-08-26 1995-08-25 Gene Therapy for Vascular Disease Using Cell-Specific Active Compounds That Change with the Cell Cycle
CA002198473A CA2198473A1 (en) 1994-08-26 1995-08-25 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
AU35185/95A AU695458B2 (en) 1994-08-26 1995-08-25 Genetic therapeutic treatment of diseases of the central nervous system (CNS) with a cell-specific active compound which is dependent on the cell cycle
FI970674A FI113787B (en) 1994-08-26 1997-02-18 Vector for expression of gene product in the cell
FI970768A FI970768A (en) 1994-08-26 1997-02-24 Gene therapeutic treatment of tumors with an endothelial cell-specific active substance dependent on the cell cycle
GR20000401227T GR3033535T3 (en) 1994-08-26 2000-05-31 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle
GR20000401226T GR3033534T3 (en) 1994-08-26 2000-05-31 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle
GR20010400149T GR3035322T3 (en) 1994-08-26 2001-01-31 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
GR20010400847T GR3035994T3 (en) 1994-08-26 2001-06-06 Genetic therapy of tumours with an endothelium cell-specific active substance which is dependent on the cell cycle
US10/112,953 US20030018005A1 (en) 1994-08-26 2002-04-02 Gene therapy of diseases associated with the immune system, using a cell-specific active compound which is regulated by the cell cycle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9417366A GB9417366D0 (en) 1994-08-26 1994-08-26 Cell cycle regulated repressor and DNA element

Publications (1)

Publication Number Publication Date
GB9417366D0 true GB9417366D0 (en) 1994-10-19

Family

ID=10760519

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9417366A Pending GB9417366D0 (en) 1994-08-26 1994-08-26 Cell cycle regulated repressor and DNA element

Country Status (3)

Country Link
GB (1) GB9417366D0 (en)
RU (1) RU2197992C2 (en)
ZA (1) ZA957074B (en)

Also Published As

Publication number Publication date
ZA957074B (en) 1997-02-24
RU2197992C2 (en) 2003-02-10

Similar Documents

Publication Publication Date Title
IL105874A0 (en) New dna sequences and their uses
GB9417831D0 (en) Biological manipulation
PL320565A1 (en) Substances and their application
EP0752472A4 (en) Novel gene originating in corynebacterium and use thereof
IL121306A0 (en) Cell cycle checkpoint pik-related kinase materials and methods
EP0794962A4 (en) Dna-binding factor ctcf
HUT77108A (en) Dna sequence and its use
EP0774510A4 (en) Ungulate eg cell
EP0465132A3 (en) Dna and its use
GB9423372D0 (en) Proteins and their uses
CZ98695A3 (en) Contacting between control and representation means and structural groups
GB9417366D0 (en) Cell cycle regulated repressor and DNA element
GB9415129D0 (en) Oligonucleotides and their use
GB2327504B (en) Improvements in and relating to durometers
GB2288092B (en) Sample and hold arrangement
EP1012160A4 (en) Tango-72 and tango-77 nucleic acid molecules and polypeptides
EP1007682A4 (en) Novel nucleic acid molecules and uses therefor
GB9310227D0 (en) Protein and dna
ZA953488B (en) A novel brain endothelial cell protein and methods for its use
IL136693A0 (en) V196 dna and polypeptides
NO970756L (en) Cell cycle-regulated repressor and DNA element
GB9408939D0 (en) Cell modification
GB9424918D0 (en) Substances and their uses
GB9424939D0 (en) Substances and their uses
GB9424915D0 (en) Substances and their uses